Trial
NCT02581059
Efficacy of Ginseng for Patients on Regorafenib
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
Bayer; Hoosier Cancer Research Network
Condition
Colorectal Cancer
Intervention
Regorafenib
Why stopped
Funder terminated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-26